PW Medtech Group (HKSE:01358) FCF Margin % : 23.84% (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is PW Medtech Group FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. PW Medtech Group's Free Cash Flow for the six months ended in Dec. 2023 was HK$92.8 Mil. PW Medtech Group's Revenue for the six months ended in Dec. 2023 was HK$389.5 Mil. Therefore, PW Medtech Group's FCF Margin % for the quarter that ended in Dec. 2023 was 23.84%.

As of today, PW Medtech Group's current FCF Yield % is 8.28%.

The historical rank and industry rank for PW Medtech Group's FCF Margin % or its related term are showing as below:

HKSE:01358' s FCF Margin % Range Over the Past 10 Years
Min: -26.6 Med: 4.12 Max: 38.63
Current: 19.13

During the past 12 years, the highest FCF Margin % of PW Medtech Group was 38.63%. The lowest was -26.60%. And the median was 4.12%.

HKSE:01358's FCF Margin % is ranked better than
92.02% of 827 companies
in the Medical Devices & Instruments industry
Industry Median: -7.1 vs HKSE:01358: 19.13

PW Medtech Group FCF Margin % Historical Data

The historical data trend for PW Medtech Group's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PW Medtech Group FCF Margin % Chart

PW Medtech Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

14.52

28.43

9.55

38.63

19.13

PW Medtech Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-6.88	51.27	30.23	13.87	23.84

Competitive Comparison of PW Medtech Group's FCF Margin %

For the Medical Instruments & Supplies subindustry, PW Medtech Group's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PW Medtech Group's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PW Medtech Group's FCF Margin % distribution charts can be found below:

* The bar in red indicates where PW Medtech Group's FCF Margin % falls into.

PW Medtech Group FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

PW Medtech Group's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	141.228	/	738.393
	=	19.13 %

PW Medtech Group's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	92.836	/	389.461
	=	23.84 %

PW Medtech Group FCF Margin % Related Terms

Thank you for viewing the detailed overview of PW Medtech Group's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

PW Medtech Group (HKSE:01358) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PW Medtech Group Ltd (HKSE:01358) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

PWE:Germany

Address

Building 1, No. 23 Panlong West Road, Pinggu District, Beijing, CHN, 101204

Website

https://www.pwmedtech.com

PW Medtech Group Ltd is a medical device company with a focus on fast-growing and high-margin segments of China's medical device industry. The company is engaged in the research and development, manufacturing, and sale of the advanced infusion set, intravenous cannula products, and insulin needles. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, and insulin needles and pens. The company operates through three business segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business.

Executives

Right Faith Holdings Limited	2101 Beneficial owner
Chan Marc	2201 Interest of corporation controlled by you
Fil Limited	2201 Interest of corporation controlled by you
Pandanus Associates Inc.	2201 Interest of corporation controlled by you
Pandanus Partners L.p.	2201 Interest of corporation controlled by you
Fidelity China Special Situations Plc	2101 Beneficial owner
Cross Mark Limited	2101 Beneficial owner
Liu Yufeng	2201 Interest of corporation controlled by you
Zhang Zaixian	2202 Interest of your spouse

PW Medtech Group (HKSE:01358) Headlines

No Headlines